Veterinary Medicine Information website

Cryomarex (Rispens + HVT)

Not authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus 3, strain F126, Live
Download as PDF

Product identification

Medicine name:
Cryomarex (Rispens + HVT)
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus 3, strain F126, Live
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    1000.00
    plaque forming unit
    /
    1.00
    Vial
  • Turkey herpesvirus 3, strain F126, Live
    1000.00
    plaque forming unit
    /
    1.00
    Vial
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • MEB
Authorisation number:
  • REG NL 7908
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 30/01/2023
Download